Welcome to our dedicated page for Bruker Corporation news (Ticker: BRKR), a resource for investors and traders seeking the latest updates and insights on Bruker Corporation stock.
Bruker Corporation (symbol: BRKR) stands as a global leader in analytical instrumentation. With over fifty years of innovation, Bruker aims to provide top-tier technological solutions for various analytical tasks. Headquartered in Massachusetts, USA, Bruker employs more than 6,500 individuals across 90 locations worldwide.
The company's operations are categorized into four main segments:
- BSI BioSpin: Specializes in magnetic resonance technologies, including NMR, EPR, and preclinical MRI systems.
- BSI CALID: Focuses on mass spectrometry, chromatography, molecular spectroscopy, and in vitro diagnostics.
- BSI Nano: Offers solutions in X-ray diffraction, elemental analysis, atomic force microscopy, and surface and dimensional metrology.
- Bruker Energy & Supercon Technologies (BEST): Provides superconducting materials and devices for energy, science, and healthcare sectors.
Bruker demonstrates a strong commitment to research and development, continuously expanding its suite of products and maintaining a robust installed base globally. The company’s dedication to quality and reliability is reflected in its significant presence in the Asia Pacific region, which accounts for the largest share of its revenue.
Recent achievements include advancements in mass spectrometry and collaborations with leading pharmaceutical and biotechnology companies. Bruker's technologies are vital for quality assurance in industrial production processes, supporting customers in ensuring precision and reliability.
Bruker Corporation is not just a manufacturer but a partner in innovation, helping scientists and researchers address complex analytical challenges with integrity and cutting-edge technology.
Rhea-AI Summary
Bruker (BRKR) has been named the Instrument Business Outlook (IBO) 'Company of the Year' for 2023 due to its impressive double-digit organic revenue growth across all major regions and business groups. The company's innovative model, management processes, and disciplined entrepreneurial culture have led to significant portfolio transformation and sustainable growth. Bruker's strategic initiatives like Project Accelerate 2.0 and Operational Excellence position it as a leader in the post-genomic era, with anticipated strong growth for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
-
Rhea-AI Summary
Bruker Corporation (BRKR) announces advancements in immunopeptidomics, glycoproteomics, and other 4D-proteomics workflows at the 20th US Human Proteome Organization Congress 2024. The company introduces innovative software, methods, and tools to enhance post-genomic research, disease biology insights, and biomarker discovery.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
-
Rhea-AI Summary
Bruker Corporation (BRKR) successfully closes the acquisition of Chemspeed Technologies AG, a Swiss provider of automated laboratory solutions, marking a significant milestone in Bruker's expansion. The acquisition aligns with Bruker's strategic Project Accelerate 2.0 portfolio transformation, focusing on scientific software, R&D, QC digitalization, and laboratory automation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
News
Rhea-AI Summary
Bruker Corporation (BRKR) to Acquire ELITechGroup for €870 Million in Cash, Excluding Clinical Chemistry Business
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.32%
Tags
-
Rhea-AI Summary
Bruker Corporation (BRKR) announces CFO's participation in upcoming investor conferences in New York City and Boston. Webcasts and replays will be available on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.26%
Tags
-
Rhea-AI Summary
Bruker Corporation (BRKR) declares a quarterly cash dividend of $0.05 per share on its common stock, payable on March 15, 2024, to stockholders of record as of March 1, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.88%
Tags
Rhea-AI Summary
Bruker Corporation (BRKR) reports strong Q4 2023 revenues of $854.5 million, up 20.6% yoy, with organic revenue growth of 15.9%. GAAP EPS of $1.41, including a gain on PhenomeX acquisition. Full year 2023 revenues of $2.96 billion, up 17.1% yoy, with organic growth of 14.5%. FY 2023 non-GAAP EPS up 10.3% yoy. Bruker expects 2024 revenue growth of 8% to 10% yoy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.77%
Tags
-
Rhea-AI Summary
Bruker Corporation (Nasdaq: BRKR) has announced the acquisition of Nanophoton Corporation, a pioneer in advanced research Raman microscopy systems. Nanophoton's acquisition fills a gap in Bruker's molecular microscopy portfolio, offering fast, flexible, and sensitive Raman microscopy systems worldwide for research and development in various industries. The acquisition is expected to enhance Bruker's molecular microscopy portfolio, offering exceptional speed, sensitivity, and spatial resolution. Nanophoton's CEO founder expressed excitement about the partnership with Bruker, while the President of Bruker Optics division welcomed the Nanophoton team and acknowledged their expertise in innovating Raman microscopy. Financial terms of the acquisition were not disclosed, but in 2023, Nanophoton Corporation had revenues of approximately $5 million and was near break-even.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.3%
Tags
-
Rhea-AI Summary
Bruker Corporation (Nasdaq: BRKR) has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems. The acquisition fills a gap in Bruker's technology and product portfolio, broadening its range of preclinical solutions for disease research. SII generated revenues of over $10 million in 2023 and was profitable.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.3%
Tags
Rhea-AI Summary
Bruker Corporation (Nasdaq: BRKR) will report Q4 and fiscal year 2023 financial results on February 13, 2024. A conference call and webcast will be held to discuss the results and current business trends. Investors can listen to the webcast and earnings call via the company's website or telephone. Pre-registration for the call is available to expedite entry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.88%
Tags
FAQ
What is the current stock price of Bruker Corporation (BRKR)?
The current stock price of Bruker Corporation (BRKR) is $57 as of December 20, 2024.
What is the market cap of Bruker Corporation (BRKR)?
The market cap of Bruker Corporation (BRKR) is approximately 8.7B.
What does Bruker Corporation specialize in?
Bruker Corporation specializes in analytical instrumentation, offering solutions in magnetic resonance, mass spectrometry, X-ray analysis, and superconducting technologies.
How is Bruker Corporation structured?
Bruker operates in four main segments: BSI BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST).
Where does Bruker generate most of its revenue?
The majority of Bruker's revenue is generated from the Asia Pacific region.
How many employees does Bruker Corporation have?
Bruker Corporation employs over 6,500 people globally.
What industries does Bruker serve?
Bruker serves the life sciences, pharmaceutical, biotechnology, and industrial production sectors.
What recent advancements has Bruker made?
Bruker has made significant advancements in mass spectrometry and has formed key partnerships with leading pharmaceutical and biotechnology firms.
What is BSI BioSpin known for?
BSI BioSpin is known for its magnetic resonance technologies, including NMR, EPR, and preclinical MRI systems.
Why are Bruker's technologies important in industrial production?
Bruker's instruments ensure quality and process reliability, which are critical for precision and performance in industrial production.
What is the BEST segment of Bruker Corporation?
BEST, or Bruker Energy & Supercon Technologies, provides superconducting materials and devices for the energy, science, and healthcare sectors.
How does Bruker Corporation contribute to scientific research?
Bruker develops state-of-the-art technologies that assist scientists and researchers in addressing complex analytical questions with precision.
Bruker Corporation
Nasdaq:BRKR
BRKR Rankings
BRKR Stock Data
8.72B
103.19M
31.92%
79.77%
1.99%
Medical Devices
Laboratory Analytical Instruments
United States of America
BILLERICA